Volume 28, Issue 160 (5-2018)                   J Mazandaran Univ Med Sci 2018, 28(160): 173-181 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Niksolat F, Majidi H, Rahmatpour Rokni G, Dashti Dargahloo S, Tabarestani M, Sadr S. Successful Treatment of Scleromyxedema with IVIG: A Case Report . J Mazandaran Univ Med Sci. 2018; 28 (160) :173-181
URL: http://jmums.mazums.ac.ir/article-1-10898-en.html
Abstract:   (2124 Views)
Scleromyxedema (SM), a rare progressive cutaneous mucinosis with a systemic involvement, presents with progressive dermal mucin depositions, causing skin thickening. In addition to the skin involvement and paraproteinemia, patients with SM also have other complications. The systems which are commonly involved include the gastrointestinal, musculoskeletal, pulmonary, cardiovascular, renal, and central nervous systems. Scleromyxedema is difficult to treat. We present a patient with severe Scleromyxedema with cutaneous, gastrointestinal, musculoskeletal and renal manifestations. Following failed therapeutic attempts, she responded to treatment with intravenous gammaglobulin (IVIG), prednisolone, and azathioprine. As a result of treatment with IVIG, the patient showed dramatic improvement in her clinical symptoms and remained in remission throughout the course of combination IVIG infusions and prednisolone. We concluded that an IVIG-prednisolone combination may be an effective novel treatment of Scleromyxedema.
Full-Text [PDF 611 kb]   (496 Downloads)    
Type of Study: Case Report | Subject: Gynecology and Infertility

Add your comments about this article : Your username or Email:

Send email to the article author

© 2019 All Rights Reserved | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb